Abstract
To assess the safety profile of the 13.5 mg total content levonorgestrel intrauterine contraceptive system (LNG-IUS13.5mg; Skyla in the US, Jaydess elsewhere) over 1 year of use in postmenarcheal adolescents aged <18 years.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
